Platelet-stimulating agents encourage the body to produce more platelets.
These agents may work by different mechanisms. They can stimulate megakaryocytes, precursors of platelets, to produce platelets faster than normal or they may act as c-mpl (TpoR) receptor agonists. The c-mpl (TpoR) receptor is a target for thrombopoietin, a hormone that stimulates development of megakaryocytes.
Platelet-stimulating agents are used to treat chronic idiopathic thrombocytopenic purpura.